We then used WB to detect full-length PRSS35 and its shorter variants in clinical samples of HCC patients, which revealed that all forms of this protein were markedly decreased in HCC lesions compared to their levels in adjacent noncancerous tissues (Supplementary Fig. 1d). This evidence concerns the gene PRSS35 and hepatocellular carcinoma.